http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101304425-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101304425-B1 |
| titleOfInvention | A composition for the treatment or prevention of vascular diseases containing murayapolin a derivative as an active ingredient |
| abstract | The present invention relates to a composition having an inhibitory effect on platelet aggregation, which contains a derivative compound of Murayapoline A as an active ingredient, wherein the composition is atherosclerosis, hypertension, angina pectoris, myocardial infarction, ischemic heart disease, heart failure, carotid angioplasty It can prevent and treat vascular diseases such as postoperative complications, cerebral infarction, cerebral hemorrhage, and stroke, and can be usefully applied to various therapeutic agents that can improve the diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160094802-A |
| priorityDate | 2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.